Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 2;4(8):100496.
doi: 10.1016/j.xkme.2022.100496. eCollection 2022 Aug.

Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay

Insa M Schmidt  1 , Mia R Colona  1 , Anand Srivastava  2 , Guanghao Yu  1 , Venkata Sabbisetti  3 , Joseph V Bonventre  3 , Sushrut S Waikar  1
Affiliations

Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay

Insa M Schmidt et al. Kidney Med. .
No abstract available

Keywords: ELISA; Olink; plasma kidney injury molecule-1; proteomics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Correlation between plasma kidney injury molecule-1 (KIM-1) measurements using enzyme-linked immunosorbent assay (ELISA) and a proximity extension assay (Olink) according to systemic lupus erythematosus (SLE) status. Plasma KIM-1 (Olink) values are expressed as normalized protein expression values on a log2 scale. Plasma KIM-1 (ELISA) values were measured in pg/mL and log2-transformed.
See this image and copyright information in PMC

References

    1. Hayek SS, Raffield LM, Gao Y, et al. Assay-related differences in SuPAR levels: implications for measurement and data interpretation. medRxiv. Preprint posted online June 28, 2021. https://doi.org/10.1101/2021.06.23.21259148 - DOI - PMC - PubMed
    1. Raffield L.M., Dang H., Pratte K.A., et al. Comparison of proteomic assessment methods in multiple cohort studies. Proteomics. 2020;20(12) - PMC - PubMed
    1. Katz D.H. Abstract 9892: proteomic profiling of cardiometabolic phenotypes: a comparison of aptamer-based and antibody-based affinity platforms. Circulation. 2021;144(Suppl 1):A9892. https://www.ahajournals.org/doi/abs/10.1161/circ.144.suppl_1.9892 - DOI
    1. Liu R.X., Thiessen-Philbrook H.R., Vasan R.S., et al. Comparison of proteomic methods in evaluating biomarker-AKI associations in cardiac surgery patients. Transl Res. 2021;238:49–62. - PMC - PubMed
    1. Tin A., Yu B., Ma J., et al. Reproducibility and variability of protein analytes measured using a multiplexed modified aptamer assay. J Appl Lab Med. 2019;4(1):30–39. - PMC - PubMed

LinkOut - more resources